Assessing the role of everolimus in reducing hepatocellular carcinoma recurrence after living donor liver transplantation for patients within the UCSF criteria: re-inventing the role of mammalian target of rapamycin inhibitors

BACKGROUNDS/AIMS: The protective effect of everolimus (EVR) in hepatocellular carcinoma (HCC) patients who receive liver transplantation in terms of reducing the recurrence has not been sufficiently investigated in clinical trials. In this second stage of our ongoing study, we intend to analyze the...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ann Hepatobiliary Pancreat Surg
Main Authors: Thorat, Ashok, Jeng, Long-Bin, Yang, Horng-Ren, Yeh, Chun-Chieh, Hsu, Shih-Chao, Chen, Te-Hung, Poon, Kin-Shing
Format: Artigo
Sprog:Inglês
Udgivet: Korean Association of Hepato-Biliary-Pancreatic Surgery 2017
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5736740/
https://ncbi.nlm.nih.gov/pubmed/29264583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14701/ahbps.2017.21.4.205
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker